Your session is about to expire
← Back to Search
Behavioral Intervention
Mobile Gaming App for HIV/AIDS Medication Adherence
N/A
Waitlist Available
Led By Laura Whiteley, MD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks
Awards & highlights
Summary
This trial will test a new intervention to improve adherence to HIV medications and treatment for youth. The intervention includes a mobile gaming app that is integrated with a 7-day electronic medication device and text messages.
Who is the study for?
This trial is for English-speaking youth living with HIV who have started or restarted antiretroviral therapy (ART) in the last three months. Participants must have access to a smartphone, be able to consent, and not be involved in other HIV-related studies. They should also have a detectable viral load.
What is being tested?
The study tests a mobile gaming app designed to improve ART adherence among youth. The game integrates with an electronic medication device and sends text messages, aiming to make treatment more engaging and monitor progress.
What are the potential side effects?
Since this intervention involves using a mobile app rather than a drug, traditional side effects are not expected. However, participants may experience increased screen time which could affect sleep patterns or cause eye strain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline HIV-1 Viral Load at 48 weeks
Secondary study objectives
Self-reported Medication Adherence
Self-reported Missed ARV Doses (1 Month)
Self-reported Missed ARV Doses (1 week)
Other study objectives
Antiretroviral Therapy Treatment Knowledge
HIV Treatment Knowledge Scale
HIV Treatment Self-Efficacy
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Multilevel Gaming AdherenceExperimental Treatment1 Intervention
Participants in the intervention arm will receive Multilevel Gaming Adherence Intervention. Participants receive Battle Viro on their mobile phones, an electronic pill monitoring device, and, for 24 weeks, game-related text messages guided by medication adherence data (collected from an electronic pill monitoring device).
Group II: Treatment as Usual +Active Control1 Intervention
TAU+ participants will receive the Treatment As Usual + intervention, which includes receiving a non-HIV related mobile game and an electronic pill monitoring device.
Find a Location
Who is running the clinical trial?
Emory UniversityOTHER
1,679 Previous Clinical Trials
2,583,566 Total Patients Enrolled
Rhode Island HospitalLead Sponsor
262 Previous Clinical Trials
68,839 Total Patients Enrolled
University of Mississippi Medical CenterOTHER
179 Previous Clinical Trials
196,621 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- There are no specific exclusion criteria for this study.You have HIV.You are not participating in any other study related to preventing or managing HIV.
Research Study Groups:
This trial has the following groups:- Group 1: Multilevel Gaming Adherence
- Group 2: Treatment as Usual +
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger